Management strategies for Barrett's esophagus.
Hillman
Lybus
L
D000230:Adenocarcinoma / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D015995:Prevalence; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D012737:Sex Factors
D000897:Anti-Ulcer Agents; D052246:Cyclooxygenase 2 Inhibitors; D054328:Proton Pump Inhibitors